AI assistant
Sending…
ONCOLYTICS BIOTECH INC — Director's Dealing 2026
Jan 2, 2026
33950_dirs_2026-01-02_4f00bfbe-01cd-4c7e-b62e-39985ed1ab78.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ONCOLYTICS BIOTECH INC (ONCY)
CIK: 0001129928
Period of Report: 2026-01-01
Reporting Person: Aromando Andrew (Chief Business Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Shares | 25500 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option | $0.93 | 2030-06-25 | Common Shares (750000) | Direct | |
| Stock Option | $1.08 | 2030-08-15 | Common Shares (300000) | Direct | |
| Stock Option | $0.99 | 2030-12-15 | Common Shares (250000) | Direct |
Footnotes
F1: The stock option vests in three equal annual installments beginning on June 25, 2026.
F2: The exercise price is listed in Canadian dollars.
F3: The stock option vests in three equal annual installments beginning on August 15, 2026.
F4: The stock option vests in three equal annual installments beginning on December 15, 2026.
More from ONCOLYTICS BIOTECH INC
Regulatory Filings
2026
May 22
Regulatory Filings
2026
May 4
Regulatory Filings
2026
Apr 27
Regulatory Filings
2026
Apr 6
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 20
Regulatory Filings
2026
Mar 19
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 13